|
|
|
Insider
Information: |
Pakianathan Deepika |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
77,416 |
|
Indirect Shares
|
2,838,532 |
|
|
Direct
Value |
$670,483 |
|
|
Indirect Value
|
$53,591,484 |
|
|
Total
Shares |
2,915,948 |
|
|
Total
Value |
$54,261,967 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
8
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
8
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-8.0
|
Percentage
Gain/Loss : |
0.0%
|
-789.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2016-06-21 |
0 |
2016-06-21 |
0 |
Premium* |
|
Karyopharm Therapeutics Inc. |
KPTI |
|
2013-11-12 |
0 |
2024-06-07 |
0 |
Premium* |
|
Trivascular Technologies, Inc. |
TRIV |
10% Owner |
2014-04-22 |
0 |
2016-02-03 |
0 |
Premium* |
|
Alder Biopharmaceuticals Inc |
ALDR |
Director, 10% Owner |
2014-05-13 |
0 |
2014-05-13 |
2,838,532 |
Premium* |
|
Calithera Biosciences, Inc. |
CALA |
Director |
2014-10-07 |
0 |
2023-01-27 |
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-05-08 |
47,416 |
2020-07-01 |
0 |
Premium* |
|
Pardes Biosciences Ord Shs |
PRDS |
Director |
2021-12-23 |
30,000 |
2021-12-23 |
0 |
Premium* |
|
Mereo Biopharma Group plc |
MREO |
|
2024-08-22 |
0 |
2024-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXA |
Alexza Pharmaceuticals In... |
Director |
|
2006-03-08 |
4 |
B |
$8.00 |
$8,000 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
Director |
|
2006-03-13 |
4 |
A |
$0.00 |
$0 |
I/I |
989,678 |
979,880 |
|
- |
|
ALXA |
Alexza Pharmaceuticals In... |
Director |
|
2009-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,014 |
17,014 |
0 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
Director |
|
2010-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
18,908 |
35,922 |
0 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
Director |
|
2010-06-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,452) |
22,470 |
0 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
Director |
|
2011-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,883) |
6,587 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
Director |
|
2013-11-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,790,633 |
17,315 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
Director |
|
2013-11-12 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
20,337 |
2.1 |
- |
|
TRIV |
Trivascular Technologies,... |
10% Owner |
|
2014-04-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,702,577 |
3,535,910 |
0 |
- |
|
TRIV |
Trivascular Technologies,... |
10% Owner |
|
2014-04-22 |
4 |
B |
$12.00 |
$9,999,996 |
I/I |
833,333 |
833,333 |
1.5 |
- |
|
ALDR |
Alder Biopharmaceuticals ... |
Director |
|
2014-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,488,532 |
2,488,532 |
0 |
- |
|
ALDR |
Alder Biopharmaceuticals ... |
Director |
|
2014-05-13 |
4 |
B |
$10.00 |
$3,500,000 |
I/I |
350,000 |
2,838,532 |
2.25 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
Director |
|
2014-05-21 |
4 |
B |
$26.19 |
$2,426,874 |
I/I |
92,650 |
21,233 |
2.1 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
Director |
|
2014-05-22 |
4 |
B |
$26.09 |
$521,804 |
I/I |
20,000 |
21,426 |
2.1 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
Director |
|
2014-05-23 |
4 |
B |
$26.45 |
$46,784 |
I/I |
1,769 |
21,443 |
2.1 |
- |
|
CALA |
Calithera Biosciences, In... |
Director |
|
2014-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,926,702 |
18,629 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
Director |
|
2014-10-07 |
4 |
B |
$10.00 |
$5,000,000 |
I/I |
500,000 |
23,464 |
2.25 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
Director |
|
2015-01-12 |
4 |
B |
$33.00 |
$1,499,982 |
I/I |
45,454 |
21,883 |
2.1 |
- |
|
TRIV |
Trivascular Technologies,... |
10% Owner |
|
2016-02-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,535,910) |
0 |
0 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
Director |
|
2016-06-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(658) |
0 |
0 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
Director |
|
2016-06-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(98,967) |
0 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Director |
|
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,067 |
8,067 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Director |
|
2021-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,828 |
17,895 |
0 |
- |
|
PRDS |
Pardes Biosciences Ord Sh... |
Director |
|
2021-12-23 |
4/A |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
PRDS |
Pardes Biosciences Ord Sh... |
Director |
|
2021-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
52,500 |
52,500 |
0 |
- |
|
40 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|